Unicycive Therapeutics, Inc. Common Stock (UNCY) is a publicly traded Healthcare sector company. As of September 22, 2026, UNCY trades at $4.80 with a market cap of $133.71M and a P/E ratio of -2.86. UNCY moved -0.42% today. Year to date, UNCY is -17.33%; over the trailing twelve months it is +20.45%. Its 52-week range spans $3.71 to $11.00. Analyst consensus is strong buy with an average price target of $25.83. Rallies surfaces UNCY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
UNCY financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. UNCY recently traded at $4.80. Market cap is $133.71M. P/E ratio is -2.86. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $4.80 |
| Market Cap | $133.71M |
| P/E Ratio | -2.86 |
| EPS | $-1.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.00 |
| 52-Week Low | $3.71 |
| Volume | 402.28K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-26.55M |
| Gross Margin | 0.00% |
6 analysts cover UNCY: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $25.83.